Norbert Marschner (N Marschner)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Locally Advanced

Metastatic Renal Cell Carcinoma

Early Breast Cancer

Top Venues

International journal of cancer

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Breast cancer research and treatment

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nina Haug, Martina Jänicke, Benjamin Kasenda, Norbert Marschner, Melanie Frank
Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 33 (4) (2024)
Nina Haug, Martina Jänicke, Benjamin Kasenda, Norbert Marschner, Melanie Frank
Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2024)
Nina Haug, Martina Jänicke, Benjamin Kasenda, Norbert Marschner, Melanie Frank
Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 33 (4) (2024)
Nina Haug, Martina Jänicke, Benjamin Kasenda, Norbert Marschner, Melanie Frank
Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2024)
Nina Haug, Martina Jänicke, Benjamin Kasenda, Norbert Marschner, Melanie Frank
Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 33 (4) (2024)
Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Christian Lerchenmüller, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke, null null
Head-to-head comparison of treatment sequences in advanced pancreatic cancer-Real-world data from the prospective German TPK clinical cohort study. International journal of cancer (2024)
Norbert Marschner, Susanna Hegewisch-Becker, Marcel Reiser, Eyck von der Heyde, Mathias Bertram, Stephan H Hollerbach, Stephan Kreher, Thomas Wolf, Adrian Binninger, Marco Chiabudini, Anja Kaiser-Osterhues, Martina Jänicke, null null
FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world. International journal of cancer (2022)
Wolfgang Knauf, Wolfgang Abenhardt, Michael Koenigsmann, Christoph Maintz, Reiner Sandner, Mark-Oliver Zahn, Roland Schnell, Susanne Tech, Anja Kaiser-Osterhues, Leonora Houet, Norbert Marschner, null null
Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms. Hematological oncology 39 (3) (2021)
Michael D Staehler, Andrej Panic, Peter J Goebell, Marie Merling, Karin Potthoff, Edwin Herrmann, Patrick de Geeter, Corinne Vannier, Cathrin Hogrefe, Norbert Marschner, Viktor Grünwald
First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial. International journal of cancer 148 (4) (2020)
Wolfgang Knauf, Wolfgang Abenhardt, Hans Rainer Slawik, Ute Bückner, Burkhard Otremba, Annette Sauer, Mark-Oliver Zahn, Natalie Wetzel, Anja Kaiser-Osterhues, Leonora Houet, Norbert Marschner, null null
Rare lymphomas in routine practice-Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms. Hematological oncology 38 (3) (2020)
Michael D Staehler, Michael Stöckle, Daniel C Christoph, Arnulf Stenzl, Karin Potthoff, Marc-Oliver Grimm, Dunja Klein, Johanna Harde, Fabian Brüning, Peter J Goebell, Marinela Augustin, Frederik Roos, Iris Benz-Rüd, Norbert Marschner, Viktor Grünwald
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial. International journal of cancer 148 (7) (2020)
Wolfgang Knauf, Wolfgang Abenhardt, Johannes Mohm, Jacqueline Rauh, Johanna Harde, Anja Kaiser-Osterhues, Martina Jänicke, Norbert Marschner, null null
Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms. European journal of haematology 103 (5) (2019)
Michael Staehler, Peter J Goebell, Lothar Müller, Till-Oliver Emde, Natalie Wetzel, Lisa Kruggel, Martina Jänicke, Norbert Marschner, null null
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry. International journal of cancer 146 (5) (2019)
Norbert Marschner, M Frank, W Vach, E Ladda, A Karcher, S Winter, M Jänicke, T Trarbach
Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS). Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 21 (7) (2019)
Norbert Marschner, Tanja Trarbach, Jacqueline Rauh, Dirk Meyer, Sigrun Müller-Hagen, Johanna Harde, Stephanie Dille, Lisa Kruggel, Martina Jänicke, null null
Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project. Breast cancer research and treatment 175 (3) (2019)
Norbert Marschner, Jochen Wilke, Daniel Reschke, Florian Kaiser, Claudia Schmoor, Renate Grugel, Emil Boller
A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10). Journal of medical economics 21 (9) (2018)
Susanna Hegewisch-Becker, Ali Aldaoud, Thomas Wolf, Beate Krammer-Steiner, Hartmut Linde, Renate Scheiner-Sparna, David Hamm, Martina Jänicke, Norbert Marschner, null null
Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma. International journal of cancer 144 (5) (2018)
Wolfgang Knauf, Ali Aldaoud, Ulrich Hutzschenreuter, Martine Klausmann, Stephanie Dille, Natalie Wetzel, Martina Jänicke, Norbert Marschner, null null
Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms. Annals of hematology 97 (12) (2018)
Hans-Jürgen Hurtz, Hans Tesch, Thomas Göhler, Ulrich Hutzschenreuter, Johanna Harde, Lisa Kruggel, Martina Jänicke, Norbert Marschner, null null
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project. Breast cancer research and treatment 165 (3) (2017)
Thomas Fietz, Mark-Oliver Zahn, Andreas Köhler, Erik Engel, Melanie Frank, Lisa Kruggel, Martina Jänicke, Norbert Marschner, null null
Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study. Breast cancer research and treatment 167 (2) (2017)
Steffen Dörfel, Claus-Christoph Steffens, Dirk Meyer, Hans Tesch, Lisa Kruggel, Melanie Frank, Martina Jänicke, Norbert Marschner, null null
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study. Breast cancer (Tokyo, Japan) 25 (3) (2017)